Opioid Therapies and Cytochrome P450 Interactions

被引:48
|
作者
Gudin, Jeffrey [1 ]
机构
[1] Englewood Hosp & Med Ctr, Pain Management & Wellness Ctr, Englewood, NJ 07631 USA
关键词
Adverse drug reactions; cytochrome P450; CYP3A4; CYP2D6; drug-drug interactions; inhibitor; inducer; metabolism; prodrug; substrate; opioids; DRUG-DRUG INTERACTIONS; ST-JOHNS-WORT; CAFFEINE METABOLISM; PHARMACOGENETICS; INHIBITION; CYP2D6; PAIN; VARIABILITY; HYDROCODONE; OXYMORPHONE;
D O I
10.1016/j.jpainsymman.2012.08.013
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Adverse drug reactions are common and associated with substantial economic and human costs. Particularly among older adult populations, preventable adverse drug reactions are often caused by drug-drug interactions. All analgesics have side effect profiles and many have known drug-drug interactions. Opioids are recognized as a necessary option for managing moderate-to-severe pain, yet many opioid side effects can be enhanced by metabolic interactions within the liver, involving other drugs, diseases, or genetics. J Pain Symptom Manage 2012; 44: S4-S14. (C) 2012 U. S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:S4 / S14
页数:11
相关论文
共 50 条
  • [41] PHARMACOLOGICAL INTERACTIONS RELATED TO CYTOCHROME P450: A CASE STUDY
    Garcia-Delgado Morente, Amalia
    Garcia-Delgado Morente, Marta
    Murillo Fernandez, Ma Dolores
    FARMACEUTICOS COMUNITARIOS, 2013, 5 (01): : 20 - 21
  • [42] Cytochrome P450 and its interactions with the heme biosynthetic pathway
    DeMatteis, F
    Marks, GS
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1996, 74 (01) : 1 - 8
  • [43] A current review of cytochrome P450 interactions of psychotropic drugs
    Madhusoodanan, Subramoniam
    Velama, Umamaheswararao
    Parmar, Jeniel
    Goia, Diana
    Brenner, Ronald
    ANNALS OF CLINICAL PSYCHIATRY, 2014, 26 (02) : 120 - 138
  • [44] Interactions of phospholipase D and cytochrome P450 protein stability
    Zangar, RC
    Fan, YY
    Chapkin, RS
    BIOCHEMICAL PHARMACOLOGY, 2004, 68 (03) : 503 - 512
  • [45] Protein/protein interactions in the human cytochrome P450 system
    Burris-Hiday, Sarah D.
    Scott, Emily E.
    FASEB JOURNAL, 2022, 36
  • [46] Computational models for predicting interactions with cytochrome p450 enzyme
    Arimoto, Rieko
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2006, 6 (15) : 1609 - 1618
  • [47] Drug-associated disease: Cytochrome P450 interactions
    Mann, HJ
    CRITICAL CARE CLINICS, 2006, 22 (02) : 329 - +
  • [48] Retraction Note: Role of cytochrome P450 in drug interactions
    Zakia Bibi
    Nutrition & Metabolism, 11 (1)
  • [49] Protein/Protein Interactions in the Human Cytochrome P450 System
    Burris-Hiday, Sarah
    Scott, Emily
    FASEB JOURNAL, 2021, 35
  • [50] Interactions of cytochrome P450 2B4 with NADPH-cytochrome P450 reductase studied by fluorescent probe
    Davydov, DR
    Knyushko, TV
    Kanaeva, IP
    Koen, YM
    Samenkova, NF
    Archakov, AI
    Hoa, GHB
    BIOCHIMIE, 1996, 78 (8-9) : 734 - 743